Preview

Rational Pharmacotherapy in Cardiology

Advanced search

EFFECTS OF N-3 POLYUNSATURATED FATTY ACIDS ON LEFT VENTRICULAR FUNCTION AND FUNCTIONAL CAPACITY IN PATIENTS WITH DILATED CARDIOMYOPATHY

https://doi.org/10.20996/1819-6446-2011-7-2-246-456

Full Text:

About the Authors

S. Nodari

Italy


M. Triggiani

Italy


U. Campia

United States


A. Manerba

Italy


G. Milesi

Italy


B. M. Cesana

Italy


M. Gheorghiade

United States


L. Dei Cas

Italy


References

1. Lloyd-Jones D., Adams R.J., Brown T.M. et al. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation 2010;121:e46–e215.

2. Tavazzi L., Maggioni A.P., Marchioli R. et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1223–30.

3. Mori T.A., Watts G.F., Burke V., Hilme E., Puddey I.B., Beilin L.J. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 2000;102:1264 –9.

4. Grimsgaard S., Bonaa K.H., Hansen J.B., Myhre E.S. Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr 1998;68:52–9.

5. McVeigh G.E., Brennan G.M., Cohn J.N., Finkelstein S.M., Hayes R.J., Johnston G.D. Fish oil improves arterial compliance in non-insulindependent diabetes mellitus. Arterioscler Thromb 1994;14: 1425–9.

6. Duda M.K., O’Shea K.M., Tintinu A. et al. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc Res 2009;81:319 –27.

7. Lang R.M., Bierig M., Devereux R.B. et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440–63.

8. Kirkpatrick J.N., Vannan M.A., Narula J., Lang R.M. Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol 2007;50:381–96.

9. Wasserman K., Hansen J.E., Sue D.Y. et al. Principles of Exercise Testing and Interpretation. Philadelphia, PA: Lea and Febiger, 1987.

10. Beaver W.L., Wasserman K., Whipp B.J. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986;60:2020 –7.

11. Balady G.J., Arena R., Sietsema K. et al. Clinician’s guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010;122:191–225.

12. Ferrari R., Bachetti T., Confortini R. et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479–86.

13. Marangoni F., Colombo C., Galli C. A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies. Anal Biochem 2004;326:267–72.

14. Vargiu R., Littarru G.P., Fraschini M. et al. Enhancement of shortening velocity, power, and acto-myosin crossbridge (CB) kinetics following long-term treatment with propionyl-L-carnitine, coenzyme Q10, and omega-3 fatty acids in BIO TO-2 cardiomyopathic Syrian hamsters papillary muscle. Bio-factors 2010;36:229 –39.

15. Vargiu R., Littarru G.P., Faa G., Mancinelli R. Positive inotropic effect of coenzyme Q10, omega-3 fatty acids and propionyl-L-carnitine on papillary muscle force-frequency responses of BIO TO-2 car-diomyopathic Syrian hamsters. Biofactors 2008;32:135– 44.

16. Berecki G., Den Ruijter H.M., Verkerk A.O. et al. Dietary fish oil reduces the incidence of triggered arrhythmias in pig ventricular myocytes. Heart Rhythm 2007;4:1452– 60.

17. Pepe S., McLennan P.L. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 2002;105:2303– 8

18. Duda M.K., O’Shea K.M., Stanley W.C. Omega-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential. Cardiovasc Res 2009;84:33– 41.

19. Duda M.K., O’Shea K.M., Lei B. et al. Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 2007;76:303–10.

20. Mozaffarian D., Gottdiener J.S., Siscovick D.S. Intake of tuna or other broiled or baked fish versus fried fish and cardiac structure, function, and hemodynamics. Am J Cardiol 2006;97:216 –22.

21. Morgan D.R., Dixon L.J., Hanratty C.G, et al. Effects of dietary omega-3 fatty acid supplementation on endothelium-dependent vasodilation in patients with chronic heart failure. Am J Cardiol 2006;97:547–51.


For citation:


Nodari S., Triggiani M., Campia U., Manerba A., Milesi G., Cesana B.M., Gheorghiade M., Dei Cas L. EFFECTS OF N-3 POLYUNSATURATED FATTY ACIDS ON LEFT VENTRICULAR FUNCTION AND FUNCTIONAL CAPACITY IN PATIENTS WITH DILATED CARDIOMYOPATHY. Rational Pharmacotherapy in Cardiology. 2011;7(2):246-456. (In Russ.) https://doi.org/10.20996/1819-6446-2011-7-2-246-456

Views: 273


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)